All In MedTech

Device Trial Radar · NCT04103749

Global Prospective Case Series Using a Single-Use Duodenoscope

Last checked: Nov 19, 2026Latest source record: Dec 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

551

Actual

Start

Mar 22, 2021

Primary completion

Nov 23, 2022

Study completion Jan 5, 2023

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Sep 25, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Confirm procedural performance of the ExaltTM Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures

Conditions

  • Endoscopic Retrograde Cholangiopancreatography

Interventions

  • Exalt Model D Single-Use DuodenoscopeDevice

    Subjects will have a clinically indicated per standard of care ERCP or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Successful ERCP ProcedureTime frame: Procedure success is assessed at the end of the procedure (within 24 hours on study day 1).

Locations

22 sites in 11 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles Medical Center

    Los Angeles, California

  • University of Chicago

    Chicago, Illinois

  • Indianapolis University Hospital

    Indianapolis, Indiana

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.